Secondary Logo

Share this article on:

A Selection of Notable Papers from the Past 25 Years

doi: 10.1097/01.gme.0000547811.35670.63
Other Notable Papers

A Selection of Notable Papers from the Past 25 Years

The Editors felt that to limit this commemorative issue to just 25 articles would be a disservice to the readership. There are many other papers that have contributed to the field. In this list we present additional notable papers from our past. We are very proud to have had the opportunity to facilitate the dissemination of this information to investigators and practitioners in the field of menopause.

Eden JA, Bush T, Nand S, Wren BG. A Case-Control Study of Combined Continuous Estrogen—Progestin Replacement Therapy among Women with a Personal History of Breast Cancer. Menopause. 1995; 2: 67-72.

Gonzales GF, Villena A. Age at menopause in central Peruvian women. Menopause. 1997; 4: 39-45.

Nicholson WK, Brown AF, Gathe J, Grumbach K, Washington AE, Perez-Stable EJ. Hormone Replacement Therapy for African American Women: Missed Opportunities for Effective Intervention. Menopause. 1999; 6: 147-155.

Murkies A, Dalais FS, Briganti EM, et al. Phytoestrogens and breast cancer in postmenopausal women: a case study. Menopause. 2000; 7: 289-296.

Seeger H, Wallweiner D, Mueck A. Effect of medroxyprogesterone acetate and norethisterone on serum-stimulated and estradiol-inhibited proliferation of human coronary artery smooth muscle cells. Menopause. 2001; 8: 5-9.

Rödström K, Bengtsson C, Lissner L, Milsom I, Sundh V, Björkelund C. A longitudinal study of the treatment of hot flushes: the population study of wome in Gothenburg during a quarter of a century. Menopause. 2002; 9: 156-161.

Joffe H, Hall JE, Soares CN, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause. 2002; 9: 392-398.

Kritz-Silverstein D, Von Mühlen D, Barrett-Connor E, Bressel MA. Isoflavones and cognitive function in older women: the SOy and Postmenopausal Health in Aging (SOPHIA) Study. Menopause. 2003; 10: 196-202.

Barrett-Connor E, Laughlin G. Hormone therapy and coronary artery calcification in asymptomatic postmenopausal women: the Rancho Bernardo Study. Menopause. 2005; 12: 40-48.

Freedman R, Subramanian M. Effects of symptomatic status and the menstrual cycle on hot flash-related thermoregulatory parameters. Menopause. 2005; 12: 156-159.

Joffe H, Hall JE, Gruber S, et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently menopausal women. Menopause. 2006; 13: 411-422.

Gold EB, Bair Y, Zhang G, et al. Cross-sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women's Health Across the Nation (SWAN). Menopause. 2007; 14: 612-623.

Thurston RC, Sowers MR, Sutton-Tyrell K, et al. Adiposity and hot flashes among midlife women. Menopause. 2008; 15: 429-434.

Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause. 2009; 16: 639-643.,_coronary_heart_disease,_and_hormone.9.aspx

Thurston RC, Christie IC, Matthews KA. Hot flashes and cardiac vaginal control: a link to cardiovascular risk? Menopause. 2010; 17: 456-461.

Allison MA, Manson JE, Aragaki A, et al. Vasomotor symptoms and coronary artery calcium in postmenopausal women. Menopause. 2010; 17: 1136-1145.

Thurston RC, Sutton-Tyrell K, Everson-Rose SA, Hess R, Powel LH, Matthews KA. Hot flashes and carotid intima media thickness among midlife women. Menopause. 2011; 18: 352-358.

Szmuilowicz ED, Manson JE, Russouw JE, et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause. 2011; 18: 603-610.

Shufelt CL, Johnson BD, Berga SL, et al. Timing of hormone therapy, type of menopause, and coronary heart disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause. 2011; 18: 943-950.,_type_of_menopause,_and.5.aspx

Rocca WA, Grossardt BR, Miller VM, Shuster LT, Brown RD. Premature menopause or early menopause and risk of ischemic stroke. Menopause. 2012; 19: 272-277.

Rosen RC, Maserejian NN, Connor MK, Krychman ML, Brown CS, Goldstein I. Characteristics of premenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women. Menopause. 2012; 19: 396-405.

El Khoudary SR, Wildman RP, Matthews K, Thurston RC, Bromberger JT, Sutton-Tyrell K. Progression rates of carotid intima-media thickness and adventitial diameter during the menopausal transition. Menopause. 2013; 20: 8-14.

Clarkson TB, Ethun KF, Pajewski NM, Golden D, Floyd E, Appt SE. Effects of bazedoxifene, conjugated equine estrogens, and a tissue-selective estrogen complex containing both bazedoxifene and conjugated equine estrogens on cerebral artery atherosclerosis in postmenopausal monkeys. Menopause. 2014; 21: 8-14.,_conjugated_equine.4.aspx

Sternfeld B, Guthrie KA, Ensrud KE, et al. Efficacy of exercise for menopausal symptoms: a randomized controlled trial. Menopause. 2014; 21: 330-338.

Sun F, Sebastiani P, Schupf N, et al. Extended maternal age at birth of last child and women's longevity in the Long Life Family Study. Menopause. 2015; 22: 26-31.

Sarrel P, Portman D, Lefebvre P, et al. Incremental direct and indirect costs of untreated vasomotor symptoms. Menopause. 2015; 22: 260-266.

Simon JA, Laliberté F, Duh MS, et al. Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy. Menopause. 2016; 23: 600-610.

Freeman EW, Sammel MD, Anxiety as a risk factor for menopausal hot flashes: evidence from the Penn Ovarian Aging cohort. Menopause 2016; 23: 942-949.

Pinkerton JV, Abraham L, Bushmakin AG, Cappelleri JC, Komm BS. Relationship between changes in vasomotor symptoms and changes in menopause-specific quality of life and sleep parameters. Menopause. 2016; 23: 1060-1066.

Shadyab AH, Macera CA, Shaffer RA, et al. Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative. Menopause. 2017; 24: 35-44.

Gold EB, Crawford SL, Shelton JF, et al. Longitudinal analysis of changes in weight and waist circumferences in relation to incident vasomotor symptoms: the Study of Women's Health Across the Nation (SWAN). Menopause. 2017; 25: 9-26.

© 2018 by The North American Menopause Society.